Benefits
Visual Function for Digital Screen Users (VDT)
In a BGG-sponsored 6-week placebo-controlled trial of 60 adults doing regular screen (VDT) work, 9 mg/day of BGG's Haematococcus astaxanthin did not differ from placebo on any measure overall, but better preserved dominant-eye acuity after screen work in a small 40+ subgroup whose arms were imbalanced at week 0. The other cited eye study tested an anthocyanin, astaxanthin and lutein combination, so it cannot isolate astaxanthin's effect.
Skin Health and Photoprotection
Astaxanthin trials report benefits for skin hydration and elasticity, and one small trial found protection from UV damage (a pooled analysis found significant improvement in skin moisture and elasticity but did not find a significant reduction in wrinkle depth). The cited skin trials were small and had company-affiliated authors, and the pooled elasticity results varied widely between studies.
Athletic Performance and Recovery
Astaxanthin has been studied for exercise-related oxidative stress and endurance. In the main cited human trial, 4 mg/day for 28 days improved 20 km cycling time-trial time versus placebo in competitive cyclists (power output also rose), but only 14 of 21 completed it, so this remains a single, small-study finding.
Cognitive Function
In a 12-week placebo-controlled trial of 96 healthy adults aged 45-64 with age-related forgetfulness, astaxanthin-rich H. pluvialis extract (6 or 12 mg/day) did not differ significantly from placebo on the main cognitive tests, although some memory scores improved within the astaxanthin groups. Evidence remains preliminary.
Anti-Fatigue
In a crossover trial of 24 healthy adults with everyday fatigue, 4 weeks of an astaxanthin plus sesamin supplement improved recovery from mental fatigue after a screen task and blunted a blood oxidative-stress marker, but physical fatigue could not be assessed and the combination prevents isolating astaxanthin's effect.
Cardiovascular Support
Astaxanthin has been studied for protecting LDL from oxidation and supporting endothelial function, with modest reported effects on blood pressure and lipids; this use is not covered by the references cited on this page.
Eye Health Beyond VDT
Astaxanthin is reported to reach retinal tissue, where it is proposed to support antioxidant defense and may complement lutein/zeaxanthin, though both cited human eye trials only studied visual function in screen workers, and the one including lutein used a combination product.
Mildly lower oxidative stress marker (MDA) in placebo-controlled trials
Studied as astaxanthin in general, not AstaZine itself. A meta-analysis of 12 placebo-controlled trials (380 people) found lower blood malondialdehyde, a lipid peroxidation marker (SMD -0.95), including in the type 2 diabetes subgroup; the authors called the effect mild. In one 8-week trial of 0, 2 or 8 mg/day in 42 young women, a DNA damage marker fell but there was no effect on lipid peroxidation.
Mechanism of action
Membrane-Protective Antioxidant
In a liposome study, astaxanthin inhibited lipid peroxidation about twice as well as beta-carotene, which the authors attributed to radical trapping both at the membrane surface and inside it. In a model-membrane study, astaxanthin preserved membrane structure and cut lipid peroxidation by about 40%, while nonpolar beta-carotene and lycopene disordered the membrane and increased it. These are laboratory findings.
Anti-Inflammatory NF-kB Inhibition
Cell and animal studies show astaxanthin inhibits NF-kB activation and inflammatory gene expression including iNOS and COX-2.
Crosses Blood-Brain and Blood-Retina Barriers
Astaxanthin is reported to reach brain and retinal tissue (brain uptake has been shown in rats), which is the rationale for its cognitive and visual applications.
Mitochondrial Membrane Protection
Astaxanthin protects mitochondrial membranes from oxidation; supports cellular energy production and reduces oxidative damage.
Haematococcus pluvialis Source
H. pluvialis microalgae produces astaxanthin under stress conditions (red color when stressed); BGG cultivates in fully-closed glass-tube photobioreactors preventing contamination and ensuring consistent quality.
Clinical trials
Randomized double-blind placebo-controlled trial of BGG Haematococcus astaxanthin 9 mg/day for 6 weeks in 60 healthy adults aged 20-64 who regularly do VDT work (59 analyzed). Sponsored by BGG Japan; three of the four authors are BGG group employees.
60 adults aged 20-64 using digital screens.
Across all participants no measure differed between groups. In a stratified analysis of those aged 40+ (22 people), astaxanthin better preserved corrected dominant-eye visual acuity after VDT work at 6 weeks (p<0.05), though the astaxanthin arm lost more acuity during VDT work at week 0 (p=0.043); under-40s showed no visual-acuity difference. The authors suggested, without measuring it, that age-related ciliary muscle decline explains the age effect.
Randomized double-blind placebo-controlled study of astaxanthin-rich H. pluvialis extract (Puresta, 6 or 12 mg/day astaxanthin) for 12 weeks; funded by the supplier, Yamaha Motor.
96 healthy adults aged 45-64 with age-related forgetfulness.
No significant between-group differences on the CogHealth battery or Groton Maze Learning Test at any time point. Within groups, 12 mg/day improved delayed-recall accuracy at 12 weeks and both doses cut maze errors by week 4 (placebo by week 12). The authors judged the sample too small.
Randomized double-blind placebo-controlled crossover trial of Haematococcus astaxanthin plus sesamin (4 weeks per arm), followed by mental (screen task) and physical (ergometer) fatigue tasks; funded by FUJIFILM.
24 healthy adults aged 30-60 with everyday fatigue (Chalder score 21 or higher).
Improved subjective recovery from mental fatigue vs placebo and attenuated the task-induced rise in plasma PCOOH, an oxidative stress marker. Other secondary outcomes did not differ, the physical-fatigue effect could not be evaluated because of carry-over, and sesamin's contribution cannot be separated.